Biocidin Academy

Videos

Log in to play webinar
Webinar

Stop Bugging Me! Microorganisms as Potential Triggers in Chronic Pain Patients

Microorganisms can act as potential triggers in chronic pain patients. In this presentation, Jocelyn Strand, ND, Biocidin’s Director of Clinical Education shares her clinical experience using botanicals to effect healthy change and balance in the microbiome.
Log in to play webinar
Webinar

Clostridia Bacterial Infections: More than Just a Digestive-System Problem

Clostridium difficile is a serious digestive system pathogen. But it also causes issues beyond the gut. Functional and Integrative Medicine expert Kurt Woeller, DO, takes an in-depth look that provides help for clinicians working with patients with autoimmune, neurological, and even certain mental health conditions.
Log in to play webinar
Webinar

A Conversation about Clostridia

Listen in as Jocelyn Strand, ND, Biocidin’s Director of Clinical Education, and Functional and Integrative Medicine expert Kurt Woeller, DO, discuss treatment strategies and effective protocols for using the Biocidin line of products with Clostridia species concerns.
Log in to play webinar
Webinar

2020 Research Overview

Biocidin® is committed to participating in ongoing research to better understand the activities of the botanicals in Biocidin® formulations and to generate data that advances the entire field of botanical medicine. In this webinar, we discuss the results of studies we have conducted and preview exciting research currently underway.
Log in to play webinar
Webinar

Impact of the Oral Microbiome on Systemic Health

Over 70% of the US population over 30 years old suffers from gingival or periodontal disease – the result of dysbiosis and the development of biofilms in the mouth. Oral dysbiosis has both local and systemic effects, resulting in immune dysregulation, pathogen translocation, inflammation, and more. Protocols with Biocidin® products offer gentle and effective solutions for disrupting biofilms and supporting microbial balance in the mouth.
Log in to play webinar
Webinar

Clostridia Bacterial Concerns Part 1: Pathogenicity Mechanisms

Clostridium difficile is labeled as one of the organisms of greatest concern for antibiotic resistance by the National Institutes of Health. It can also colonize the gastrointestinal tract, creating chronic symptoms that are harder to recognize. In this first installment of a three-part series, Kurt Woeller, DO discusses the breadth of symptoms that can manifest with Clostridium difficile and other pathogenic species.
Log in to play webinar
Webinar

Clostridia Bacterial Concerns Part 2: Laboratory Testing Options

Do you see symptoms in your patients that make you suspect Clostridium difficile (C. diff)? What's the best way to confirm your suspicions? Kurt Woeller, DO, identifies the methods he finds most effective for detecting C. diff in patients, including both conventionally accepted as well as alternative techniques.
Log in to play webinar
Webinar

Clostridia Bacterial Concerns Part 3: Intervention Options

Once you've identified C. diff as the problem, what are the clinically effective therapeutics for addressing it? Longtime practitioner Kurt Woeller, DO, discusses conventional and alternative treatment methods and weighs the benefits and risks of each.
Log in to play webinar
Webinar

Part 1: The Microbiome: Short-Chain Fatty Acids and the LPS Connection


Do you wonder about the role that microbes play when you see conditions related to inflammation? In this series, Kristen Klos-Maki, DC, dives into the science that explains how overgrowth of harmful bacteria generates inflammation, and why inflammatory issues improve when we address microbiome and gut health.
Log in to play webinar
Webinar

Part 2: Systemic Disease and the LPS Connection


Now that we are aware of the microbiome, and its relationship to systemic inflammatory conditions, it becomes clear that regular evaluation of the microbiome is essential to achieve and maintain lasting therapeutic effects for our patients.
Log in to play webinar
Webinar

PART 3: The Role of Botanicals in Microbial Balance and Systemic Health

What if you could catch gut dysbiosis or increase microbial diversity before LPS became systemic and caused severe symptoms? Recent research supports the role botanicals play in producing short-chain fatty acids (SCFAs) and the modulation of gut microbiota composition, proving valuable tools to support patients with whole-body health.
Log in to play webinar
Webinar

New Approaches in Safety Protocols for Dental Procedures

Biological Dental Hygiene is a philosophy of care that promotes diagnosing root causes of dental disease, minimizing chemicals, and proactive prevention. In this 2020 presentation, Barbara Tritz, RDH, BS, MSB, presents innovative protocols that include Biocidin®TS. These protocols set the stage for safe and successful dental procedures.
Log in to play webinar
Webinar

Dysbiosis as a Root Cause of Inflammation

The microbiome – particularly in the mouth and GI tract – play a significant role in supporting health or predisposing us to disease. Join Dr. Jocelyn Strand, Biocidin's Director of Clinical Education, as she discusses the research illuminating the importance of the microbiome in neurological health, and proven botanical therapies to restore microbiome balance.
Log in to play webinar
Webinar

Biocidin®LSF: Clinically Proven Botanicals + Advanced Liposomal Technology

When enhanced intracellular uptake is needed, practitioners appreciate the bioavailability of the liposomal delivery of Biocidin®. Listen in as Dr. Jocelyn Strand, Biocidin's Director of Clinical Education, and Dr. Chris Shade, Founder and CEO of Quicksilver Scientific, discuss the marriage of clinically-proven botanicals and advanced liposomal technology.
Log in to play webinar
Webinar

Candidiasis Part I: Pathogenicity Mechanisms

Gastrointestinal candidiasis (GC) is well-known to functional and integrative medicine providers. In this article, Kurt Woeller, DO, discusses various aspects of chronic candidiasis as it relates to different health conditions and explores different mechanisms of pathogenicity including arabinose toxicity, leaky gut (intestinal permeability), invasive protein, and immune deficiency.
Biocidin Academy logo

Welcome to Biocidin® Academy. Access with your professional account login.

Don't have a professional account?

Request account